HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of structural properties for morphologic differentiation of melanosomes. III. free and protein-bound dopa and 5-S-cysteinyldopa in B16 and Harding-Passey melanomas.

Abstract
This study analyzed the free and protein-bound forms of dopa, 5-S-cysteinyldopa (5-S-CD), and 5-S-glutathionedopa (5-S-GD) in B16 and Harding-Passey (HP) mouse melanomas to investigate the role of these catechols for melanogenesis and melanosome morphogenesis, inasmuch as these tumors produce melanosomes different in color and ultrastructure, i.e., eumelanosome type in B16 and pheomelanosome type in HP. Between B16 and HP mouse melanomas, however, we found (a) no significant difference in the level of free dopa and 5-S-CD in melanosomes and tumors, although the levels of these catechols reflected well the type of melanogenesis in control hair of normal mice, (b) a significant difference in free 5-S-GD level, which might, in part, reflect the observed difference in melanogenesis, and (c) no apparent difference in the level of bound dopa and 5-S-CD in either melanosomes or tumors. Thus, the striking difference in the color of melanosomes between B16 and HP melanomas seems to be related primarily to the content--not the type--of melanin pigments.
AuthorsS Ito, K Homma, M Kiyota, K Fujita, K Jimbow
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 80 Issue 3 Pg. 207-9 (Mar 1983) ISSN: 0022-202X [Print] United States
PMID6402551 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cysteinyldopa
  • Dihydroxyphenylalanine
Topics
  • Animals
  • Cysteinyldopa (analysis)
  • Dihydroxyphenylalanine (analysis)
  • Hair (analysis)
  • Melanocytes (analysis)
  • Melanoma (analysis)
  • Mice
  • Neoplasms, Experimental (analysis)
  • Protein Binding

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: